Abstract
Subclinical and clinical bleomycin-induced pulmary toxicity (BIP) were investigated retrospectively in 9 patients with non-Hodgkin's lymphoma treated by mbination chemotherapy containing bleomycin. A crease in carbon monoxide diffusing capacity (DLCO) is found in 12.8% of patients. The cumulative risk of normal DLCO increased with the increasing total cumulive dose of bleomycin. No significant difference in the e of BIP was observed between patients receiving bleovein/Adriamycin/cyclophosphamide/vincristine/prednine (BACOP; bleomycin given at 10 mg/m2 for 4 weeks) d bleomycin/Adriamycin/cyclophosphamide/vincrise/dexamethasone/methotrexate/folinic acid (mACOD; bleomycin given at 4 mg/m2 for 3 weeks, ethotrexate given at 200 mg/m2. Monitoring for subclinil BIP should be considered in patients with non-Hodg lymphoma even if only a low dose of bleomycin was ven in the presence of other chemotherapeutic agents.
This is a preview of subscription content, log in via an institution to check access.
References
Clark EH, Woods RL, Hughes JMB (1978) Effect of blood transfusion on the carbon monoxide transfer factor in man. Clin Sci 54: 627–631
Comis RL (1990) Detecting bleomycin pulmonary toxicity: a continued conundrum. J Clin Oncol 8: 764–767
Comis RL (1992) Bleomycin pulmonary toxicity: current status and future directions. Semin Oncol 19 [Suppl]: 64–70
Crapo RO, Morris AH (1981) Standardised single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis 123: 185–190
Da Costa JL (1971) Pulmonary function studies in healthy Chinese adults in Singapore. Am Rev Respir Dis 104: 128–131
Fryer CJ, Hutchinson RJ, Krailo M, Collins RD, Constine LS, Hays DM, et al (1990) Effieacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin's disease in children: a report from the Children Cancer Study Group. J Clin Oncol 8: 1971–1980
Jules-Elysee K, White SA (1990) Bleomycin-induced pulmonary toxicity. Clin Chest Med 2: 1–20
Shapiro CL, Yeap BY, Godleski J, Jochelson MS, Shipp MA, Skarin AT, et at (1991) Drug-related pulmonary toxicity in non-Hodgkin's lymphoma-comparative results, with three different treatment regimens. Cancer 68: 699–705
Skarin AT, Rosenthal DS, Maloney WC, et al (1977) The treatment of advanced non-Hodgkin's lymphoma (NHL) with bleomycin, Adriamycin, cyclophosphamide, vincristine and prednisone. Blood 49: 759–770
Van Barneveld PWC, Veenstra G, Sleijfer DT, Van der Mark TW, Mulder NH, Schraffordt Koops H, et al (1985) Changes in pulmonary function during and after bleomycin treatment in patients with testicular carcinoma. Cancer Chemother Pharmacol 14: 168–171
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ngan, H.Y.S., Liang, R.H.S., Lam, W.K. et al. Pulmonary toxicity in patients with non-Hodgkin's lymphoma treated with bleomycin-containing combination chemotherapy. Cancer Chemother. Pharmacol. 32, 407–409 (1993). https://doi.org/10.1007/BF00735929
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00735929